<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yan T</submitter><funding>Intramural NIH HHS</funding><pagination>e21968</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10167919</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(11)</volume><pubmed_abstract>St. John's wort (SJW), from traditional herbs, activates the pregnane X receptor (PXR), a potential drug target for treating inflammatory bowel disease (IBD). However, how SJW alleviates dextran sodium sulfate (DSS)-induced experimental IBD by activating PXR is unknown. To test this, PXR-humanized, wild-type (WT) and Pxr-null mice, primary intestinal organoids cultures, and the luciferase reporter gene assays were employed. In vivo, a diet supplemented with SJW was found to activate intestinal PXR both in WT and PXR-humanized mice, but not in Pxr-null mice. SJW prevented DSS-induced IBD in PXR-humanized and WT mice, but not in Pxr-null mice. In vitro, hyperforin, a major component of SJW, activated PXR and suppressed tumor necrosis factor (TNF)α-induced nuclear factor (NF) κB translocation</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>St. John's Wort alleviates dextran sodium sulfate-induced colitis through pregnane X receptor-dependent NFκB antagonism.</pubmed_title><pmcid>PMC10167919</pmcid><funding_grant_id>ZIA BC005562</funding_grant_id><pubmed_authors>Xia Y</pubmed_authors><pubmed_authors>Hamada K</pubmed_authors><pubmed_authors>Wang P</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Yan N</pubmed_authors><pubmed_authors>Krausz KW</pubmed_authors><pubmed_authors>Yan T</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Hao H</pubmed_authors><pubmed_authors>Gonzalez FJ</pubmed_authors><pubmed_authors>Ward JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>St. John's Wort alleviates dextran sodium sulfate-induced colitis through pregnane X receptor-dependent NFκB antagonism.</name><description>St. John's wort (SJW), from traditional herbs, activates the pregnane X receptor (PXR), a potential drug target for treating inflammatory bowel disease (IBD). However, how SJW alleviates dextran sodium sulfate (DSS)-induced experimental IBD by activating PXR is unknown. To test this, PXR-humanized, wild-type (WT) and Pxr-null mice, primary intestinal organoids cultures, and the luciferase reporter gene assays were employed. In vivo, a diet supplemented with SJW was found to activate intestinal PXR both in WT and PXR-humanized mice, but not in Pxr-null mice. SJW prevented DSS-induced IBD in PXR-humanized and WT mice, but not in Pxr-null mice. In vitro, hyperforin, a major component of SJW, activated PXR and suppressed tumor necrosis factor (TNF)α-induced nuclear factor (NF) κB translocation</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-05T09:10:20.293Z</modification><creation>2025-04-05T09:10:20.293Z</creation></dates><accession>S-EPMC10167919</accession><cross_references><pubmed>34644426</pubmed><doi>10.1096/fj.202001098R</doi><doi>10.1096/fj.202001098r</doi></cross_references></HashMap>